Skip to main content Help with accessibility Skip to main navigation

SOMATROGON injection (Ngenla®▼) for treating growth disturbance in children and young people aged 3 years and over

CCG Approval Status:

Date Added: 23 - Feb - 2023
Body System:
Red

The Cheshire and Merseyside Interim Area Prescribing Group recommends the prescribing of SOMATROGON injection (Ngenla®▼), by specialists only, for treating growth disturbance in children and young people aged 3 years and over, in accordance with NICE TA863.

NHS Cheshire and Merseyside APPROVED